Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-01-05 @ 7:01 PM
Study NCT ID:
NCT04107103
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2019-09-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma
Sponsor:
AHS Cancer Control Alberta
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-16
First Submit QC Date:
None
Study First Post Date:
2019-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL